218P Systemic inflammatory index (SII) in neuroendocrine tumors (NETs) treated with peptide receptor radionuclide therapy (PRRT) [PDF]
E. Terán Brage +11 more
openalex +1 more source
Peptide Receptor Radionuclide Therapy-Induced Hypercortisolemic Crisis in Ectopic Cushing Syndrome. [PDF]
Pandit R +5 more
europepmc +1 more source
Advancing patient education in PRRT through large language models: challenges and potential. [PDF]
Speicher T +6 more
europepmc +1 more source
Alpha Therapy Beyond TOC and TATE-Production, Quality Control, and In-Human Results for the SSTR2 Antagonist DOTA-LM3. [PDF]
Greifenstein L +8 more
europepmc +1 more source
Disseminated Intravascular Coagulation Following ¹⁷⁷Lu-Dotatate Therapy in a Patient With Metastatic Midgut Neuroendocrine Tumour: A Case Report. [PDF]
Sharif H, McRae S.
europepmc +1 more source
Treatment planning for molecular radiotherapy: potential and prospects [PDF]
Aldridge, Matt +14 more
core
Emerging Diagnostics and Therapies in Neuroendocrine Neoplasms: A Critical Review. [PDF]
Hernandez-Felix JH +5 more
europepmc +1 more source
Contrast-Enhanced Ultrasound and Somatostatin Receptor Scintigraphy Unveil an Occult Neuroendocrine Tumor With Carcinoid Syndrome and Presumed Small Intestinal Origin - A Case Report. [PDF]
Sato T +21 more
europepmc +1 more source
Cardiac Metastases in Neuroendocrine Neoplasms: A Single-Center Experience of Clinical Characteristics and Outcomes. [PDF]
Lewetag RD +11 more
europepmc +1 more source
Role of <sup>18</sup>F-AlF-NOTATATE PET/CT in selecting pediatric neuroblastoma candidates for <sup>177</sup>Lu-DOTATATE peptide receptor radionuclide therapy. [PDF]
Liu Y +6 more
europepmc +1 more source

